Fingerprint
Dive into the research topics of 'Development of PEGylated doxorubicin-E-[c(RGDfK)2] conjugate for integrin-targeted cancer therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Development of PEGylated doxorubicin-E-[c(RGDfK)2] conjugate for integrin-targeted cancer therapy
Dina Polyak, Claudia Ryppa, Anat Eldar-Boock, Paula Ofek, Ariel Many, Kai Licha, Felix Kratz, Ronit Satchi-Fainaro*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations